These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 17068401

  • 1. [The benefits and risks of hormonal replacement therapy--an update].
    Schmidt M, Kimmig R.
    Gynakol Geburtshilfliche Rundsch; 2006; 46(4):166-73. PubMed ID: 17068401
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Hormone replacement therapy for internal risk patients].
    Mueck AO.
    Gynakol Geburtshilfliche Rundsch; 2006; 46(4):174-90. PubMed ID: 17068402
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR, Gadducci A, Gambacciani M.
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H.
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Recent concerns surrounding HRT.
    Armitage M, Nooney J, Evans S.
    Clin Endocrinol (Oxf); 2003 Aug; 59(2):145-55. PubMed ID: 12864790
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.
    Sammartino A, Cirillo D, Mandato VD, Di Carlo C, Nappi C.
    J Endocrinol Invest; 2005 Aug; 28(10 Suppl):80-4. PubMed ID: 16550729
    [Abstract] [Full Text] [Related]

  • 13. [Indications for hormone replacement therapy].
    Birkhäuser MH.
    Ther Umsch; 2000 Oct; 57(10):635-42. PubMed ID: 11081375
    [Abstract] [Full Text] [Related]

  • 14. [Postmenopausal hormonal treatment: conventional hormone replacement therapy or tibolone? Effects on bone].
    Reginster JY.
    J Gynecol Obstet Biol Reprod (Paris); 2002 Oct; 31(6):541-9. PubMed ID: 12407324
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Postmenopausal hormone therapy: from monkey glands to transdermal patches.
    Davis SR, Dinatale I, Rivera-Woll L, Davison S.
    J Endocrinol; 2005 May; 185(2):207-22. PubMed ID: 15845914
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Where are we with postmenopausal hormone therapy in 2005?
    Lam PM, Chung TK, Haines C.
    Gynecol Endocrinol; 2005 Nov; 21(5):248-56. PubMed ID: 16373243
    [Abstract] [Full Text] [Related]

  • 20. Hormone replacement therapy in postmenopausal women.
    Prelevic GM, Kocjan T, Markou A.
    Minerva Endocrinol; 2005 Mar; 30(1):27-36. PubMed ID: 15877011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.